mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.002 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.003 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.003 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |